Physical ExertionCRSNCT03155633
Run, Recovery, Repeat, Always Healthy ("Corre, Recupera, Repite, Siempre Saludable")
A study testing Athletics track and Elliptical machine in people with Physical Exertion, run by Universitat Jaume I.
Trial summary
This study has as main objective to know how the processes of recovery are realized after a race of marathon. For this, the participants of a marathon race are divided into three work groups during the 9 days post-marathon, one with rest in the recovery period, another with continuous race three sessions every 48h and… Read more about this study
- Who is it for?
- Ages 30 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Physical Exertion
- What is being tested?
- Athletics track and Elliptical machine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 98 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2016to 30 Nov 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Adults healthy with 30-45 years
- BMI between 16-24,99
- Time in marathon between 3h-4h in men
- Time in marathon between 3h:30min-4h:40min in women
Who cannot join
- Having heart disease
- Having kidney disease
- Taking a medication on an ongoing basis
About this study
Official title: "Corre, Recupera, Repite, Siempre Saludable".
This study has as main objective to know how the processes of recovery are realized after a race of marathon. For this, the participants of a marathon race are divided into three work groups during the 9 days post-marathon, one with rest in the recovery period, another with continuous race three sessions every 48h and another with three sessions of elliptical every 48h .
Read the detailed description
The marathon runners suffer a high fatigue, as has been studied by different investigations, the proposal of this study is to know how the recovery processes are produced in runners who have completed a 42km test.
To do this, baseline measurements of the runners have been made through stress tests and determinations of biomarkers in blood and urine. Subsequently blood and urine samples were taken the day before the marathon test and blood and urine samples were then taken again on arrival at 24h, 48h, 96h, 144h, and 196h.
At the same time, an intervention was carried out in the recovery phase, with the runners in three groups. The first one performed rests during the 9 days after the race, the second performed continuous race monitored every 48h from the end of the race, and the third group performed aerobic work on an elliptical machine under the same conditions as the group of Continuous race
- Conditions
- Physical Exertion
- Being tested
- Athletics track, Elliptical machine
- Keywords
- Marathon, runners, biomarkers, recovery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Athletics trackOther
Running at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices
Elliptical machineOther
Running at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices
| Study group | Role | What they receive |
|---|---|---|
| Rest Group | No intervention | Rest during the 9 days after the race |
| Running Group | Experimental | Running at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices Receives: Other: Athletics track |
| Elliptical Group | Experimental | Running at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices Receives: Other: Elliptical machine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in the Blood Physiological parameters
Blood test
Measured: baseline, 0, 24, 48, 96, 144 and 192 hours post-race
Analysis of tne changes in the Physical activity data
Physical activity measured by wearing accelerometer devices. Physical activity defined as sedentary, light, moderate and vigorous. The aim to wear accelerometers devices is to monitor individuals during recovery time post-marathon race
Measured: One month before the pre-race, accelerometers were worn during seven days. Accelerometers were also worn during nine days starting from the night before the marathon race
Change in the Urin Physiological parameters
Urin test
Measured: baseline, 0, 48, 96, 144 and 192 hours post-race
Secondary outcomes (6)
Self-reported questionnaire
Personal questionnaire asking for social and training habits
Measured: One month before the race day
Strength level
Squat Jump (cm). Two jumps per person
Measured: pre-marathon race and 0, 48, 96, 144 hours post-marathon race
Analysis of the change of body mass index
BMI
Measured: one month before the marathon race day, 24 hours before the marathon race, 2 hours before the marathon race and 10 minutes after the marathon race
Physical Condition
Maximal oxygen consumption
Measured: One month before the marathon race day
Body composition
Bioimpedance analysis
Measured: One month before the marathon race day
Heart rate
Recording the number of contractions of the heart per minute (bpm) by using a heart rate monitor during all the marathon race
Measured: Through marathon completion, an average of 4 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 May 2017
- Study start1 Jun 2016
- Primary completion20 Oct 2016
- Study completion30 Nov 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Physical ExertionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The first one performed rests during the 9 days after the race, the second performed continuous race monitored every 48h from the end of the race, and the third group performed aerobic work on an elliptical machine under the same conditions as the group of Continuous race
- Masking
- None (open label)
- Enrolment
- 98 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitat Jaume I
- Sponsor type
- University, hospital or other
- Collaborators
- Fundación Trinidad Alfonso, Fundación Hospitales NISA, SD. Correcaminos
- Responsible party
- Principal investigator, Carlos Hernando, Universitat Jaume I
- Investigators
- Carlos Hernando, Principal investigator, Universitat Jaume I
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03155633
- Sponsor's protocol ID
- UJI_CRS001
- Acronym
- CRS
- Status last verified
- May 2017
- First submitted
- 26 Apr 2017
- Last updated
- 16 May 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data are administered by the Investigator Principal, other researchers must request the data they need by written request
Publications
Knechtle B, Nikolaidis PT, Zingg MA, Rosemann T, Rust CA. Differences in age of peak marathon performance between mountain and city marathon running - The 'Jungfrau Marathon' in Switzerland. Chin J Physiol. 2017 Feb 28;60(1):11-22. doi: 10.4077/CJP.2017.BAE400.
PubMed 28052642Roca E, Nescolarde L, Lupon J, Barallat J, Januzzi JL, Liu P, Cruz Pastor M, Bayes-Genis A. The Dynamics of Cardiovascular Biomarkers in non-Elite Marathon Runners. J Cardiovasc Transl Res. 2017 Apr;10(2):206-208. doi: 10.1007/s12265-017-9744-2. Epub 2017 Apr 5.
PubMed 28382580Santos VC, Sierra AP, Oliveira R, Cacula KG, Momesso CM, Sato FT, Silva MB, Oliveira HH, Passos ME, de Souza DR, Gondim OS, Benetti M, Levada-Pires AC, Ghorayeb N, Kiss MA, Gorjao R, Pithon-Curi TC, Cury-Boaventura MF. Marathon Race Affects Neutrophil Surface Molecules: Role of Inflammatory Mediators. PLoS One. 2016 Dec 2;11(12):e0166687. doi: 10.1371/journal.pone.0166687. eCollection 2016.
PubMed 27911915Niemela M, Kangastupa P, Niemela O, Bloigu R, Juvonen T. Individual responses in biomarkers of health after marathon and half-marathon running: is age a factor in troponin changes? Scand J Clin Lab Invest. 2016 Nov;76(7):575-580. doi: 10.1080/00365513.2016.1225122. Epub 2016 Sep 9.
PubMed 27609306Kim YJ, Ahn JK, Shin KA, Kim CH, Lee YH, Park KM. Correlation of Cardiac Markers and Biomarkers With Blood Pressure of Middle-Aged Marathon Runners. J Clin Hypertens (Greenwich). 2015 Nov;17(11):868-73. doi: 10.1111/jch.12591. Epub 2015 Jun 13.
PubMed 26073606Tojima M, Noma K, Torii S. Changes in serum creatine kinase, leg muscle tightness, and delayed onset muscle soreness after a full marathon race. J Sports Med Phys Fitness. 2016 Jun;56(6):782-8. Epub 2015 Feb 10.
PubMed 25665742Knechtle B, Knechtle P, Rosemann T, Lepers R. Personal best marathon time and longest training run, not anthropometry, predict performance in recreational 24-hour ultrarunners. J Strength Cond Res. 2011 Aug;25(8):2212-8. doi: 10.1519/JSC.0b013e3181f6b0c7.
PubMed 21642857Knechtle B, Knechtle P, Barandun U, Rosemann T, Lepers R. Predictor variables for half marathon race time in recreational female runners. Clinics (Sao Paulo). 2011;66(2):287-91. doi: 10.1590/s1807-59322011000200018.
PubMed 21484048Martinez-Navarro I, Montoya-Vieco A, Collado E, Hernando B, Panizo N, Hernando C. Muscle Cramping in the Marathon: Dehydration and Electrolyte Depletion vs. Muscle Damage. J Strength Cond Res. 2022 Jun 1;36(6):1629-1635. doi: 10.1519/JSC.0000000000003713. Epub 2020 Aug 12.
PubMed 32796418
Study at a glance
From the registry record, last updated by the sponsor on 16 May 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- "Corre, Recupera, Repite, Siempre Saludable".
- ClinicalTrials.gov ID
- NCT03155633
- Acronym / sponsor ID
- CRS / UJI_CRS001
- Conditions
- Physical Exertion
- Keywords
- Marathon, runners, biomarkers, recovery
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 98 participants (actual)
- Lead sponsor
- Universitat Jaume IUniversity, hospital or other
- Collaborators
- Fundación Trinidad Alfonso, Fundación Hospitales NISA, SD. Correcaminos
- Study start
- 1 Jun 2016 (actual)
- Primary completion
- 20 Oct 2016 (actual)
- Study completion
- 30 Nov 2016 (actual)
- First posted
- 16 May 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study has as main objective to know how the processes of recovery are realized after a race of marathon. For this, the participants of a marathon race are divided into three work groups during the 9 days post-marathon, one with rest in the recovery period, another with continuous race three sessions every 48h and another with three sessions of elliptical every 48h .
Detailed description
The marathon runners suffer a high fatigue, as has been studied by different investigations, the proposal of this study is to know how the recovery processes are produced in runners who have completed a 42km test.
To do this, baseline measurements of the runners have been made through stress tests and determinations of biomarkers in blood and urine. Subsequently blood and urine samples were taken the day before the marathon test and blood and urine samples were then taken again on arrival at 24h, 48h, 96h, 144h, and 196h.
At the same time, an intervention was carried out in the recovery phase, with the runners in three groups. The first one performed rests during the 9 days after the race, the second performed continuous race monitored every 48h from the end of the race, and the third group performed aerobic work on an elliptical machine under the same conditions as the group of Continuous race
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- The first one performed rests during the 9 days after the race, the second performed continuous race monitored every 48h from the end of the race, and the third group performed aerobic work on an elliptical machine under the same conditions as the group of Continuous race
| Arm | Type | Receives |
|---|---|---|
| Rest Group | No intervention | –Rest during the 9 days after the race |
| Running Group | Experimental | Other: Athletics trackRunning at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices |
| Elliptical Group | Experimental | Other: Elliptical machineRunning at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices |
Who may qualify
- Ages
- 30 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Adults healthy with 30-45 years
- BMI between 16-24,99
- Time in marathon between 3h-4h in men
- Time in marathon between 3h:30min-4h:40min in women
Key exclusion criteria (3 listed)
- Having heart disease
- Having kidney disease
- Taking a medication on an ongoing basis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Athletics trackRunning at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices | Other | Running Group |
| Elliptical machineRunning at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices | Other | Elliptical Group |
Primary outcome
Change in the Blood Physiological parameters
Time frame: baseline, 0, 24, 48, 96, 144 and 192 hours post-race
Blood test
Analysis of tne changes in the Physical activity data
Time frame: One month before the pre-race, accelerometers were worn during seven days. Accelerometers were also worn during nine days starting from the night before the marathon race
Physical activity measured by wearing accelerometer devices. Physical activity defined as sedentary, light, moderate and vigorous. The aim to wear accelerometers devices is to monitor individuals during recovery time post-marathon race
Change in the Urin Physiological parameters
Time frame: baseline, 0, 48, 96, 144 and 192 hours post-race
Urin test
6 secondary outcomes
Self-reported questionnaire
Time frame: One month before the race day
Strength level
Time frame: pre-marathon race and 0, 48, 96, 144 hours post-marathon race
Analysis of the change of body mass index
Time frame: one month before the marathon race day, 24 hours before the marathon race, 2 hours before the marathon race and 10 minutes after the marathon race
Physical Condition
Time frame: One month before the marathon race day
Body composition
Time frame: One month before the marathon race day
Heart rate
Time frame: Through marathon completion, an average of 4 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 May 2017.
- Background: PubMed 28052642Knechtle B, Nikolaidis PT, Zingg MA, Rosemann T, Rust CA. Differences in age of peak marathon performance between mountain and city marathon running - The 'Jungfrau Marathon' in Switzerland. Chin J Physiol. 2017 Feb 28;60(1):11-22. doi: 10.4077/CJP.2017.BAE400.
- Background: PubMed 28382580Roca E, Nescolarde L, Lupon J, Barallat J, Januzzi JL, Liu P, Cruz Pastor M, Bayes-Genis A. The Dynamics of Cardiovascular Biomarkers in non-Elite Marathon Runners. J Cardiovasc Transl Res. 2017 Apr;10(2):206-208. doi: 10.1007/s12265-017-9744-2. Epub 2017 Apr 5.
- Background: PubMed 27911915Santos VC, Sierra AP, Oliveira R, Cacula KG, Momesso CM, Sato FT, Silva MB, Oliveira HH, Passos ME, de Souza DR, Gondim OS, Benetti M, Levada-Pires AC, Ghorayeb N, Kiss MA, Gorjao R, Pithon-Curi TC, Cury-Boaventura MF. Marathon Race Affects Neutrophil Surface Molecules: Role of Inflammatory Mediators. PLoS One. 2016 Dec 2;11(12):e0166687. doi: 10.1371/journal.pone.0166687. eCollection 2016.
- Background: PubMed 27609306Niemela M, Kangastupa P, Niemela O, Bloigu R, Juvonen T. Individual responses in biomarkers of health after marathon and half-marathon running: is age a factor in troponin changes? Scand J Clin Lab Invest. 2016 Nov;76(7):575-580. doi: 10.1080/00365513.2016.1225122. Epub 2016 Sep 9.
- Background: PubMed 26073606Kim YJ, Ahn JK, Shin KA, Kim CH, Lee YH, Park KM. Correlation of Cardiac Markers and Biomarkers With Blood Pressure of Middle-Aged Marathon Runners. J Clin Hypertens (Greenwich). 2015 Nov;17(11):868-73. doi: 10.1111/jch.12591. Epub 2015 Jun 13.
- Background: PubMed 25665742Tojima M, Noma K, Torii S. Changes in serum creatine kinase, leg muscle tightness, and delayed onset muscle soreness after a full marathon race. J Sports Med Phys Fitness. 2016 Jun;56(6):782-8. Epub 2015 Feb 10.
- Background: PubMed 21642857Knechtle B, Knechtle P, Rosemann T, Lepers R. Personal best marathon time and longest training run, not anthropometry, predict performance in recreational 24-hour ultrarunners. J Strength Cond Res. 2011 Aug;25(8):2212-8. doi: 10.1519/JSC.0b013e3181f6b0c7.
- Background: PubMed 21484048Knechtle B, Knechtle P, Barandun U, Rosemann T, Lepers R. Predictor variables for half marathon race time in recreational female runners. Clinics (Sao Paulo). 2011;66(2):287-91. doi: 10.1590/s1807-59322011000200018.
- Derived from this study: PubMed 32796418Martinez-Navarro I, Montoya-Vieco A, Collado E, Hernando B, Panizo N, Hernando C. Muscle Cramping in the Marathon: Dehydration and Electrolyte Depletion vs. Muscle Damage. J Strength Cond Res. 2022 Jun 1;36(6):1629-1635. doi: 10.1519/JSC.0000000000003713. Epub 2020 Aug 12.
- Individual participant dataSharing planned: Yes. The data are administered by the Investigator Principal, other researchers must request the data they need by written request
Related trials for Physical Exertion
Not yet recruiting
Beyond Voluntary Effort: Reliability and Validity of Magnetic Femoral Nerve Stimulation for Assessing Quadriceps Strength in Critically Ill Patient
Critical Illness, ICU-acquired Weakness
RecruitingObservational study
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
Spinal Muscular Atrophy
Not yet recruitingObservational study
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis)
RecruitingEarly Phase 1
Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort
Fatigue Syndrome, Chronic
Not yet recruiting
Multimodal Differences in Effort-based Decision-Making in Depression
Depression, Anhedonia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carlos Hernando principal investigator
Universitat Jaume I
Questions about this trial
What is this clinical trial studying?
A study testing Athletics track and Elliptical machine in people with Physical Exertion, run by Universitat Jaume I.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 May 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in the Blood Physiological parameters (time frame: baseline, 0, 24, 48, 96, 144 and 192 hours post-race). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03155633, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2017.